State DC
Clinical Trials in Washington D.C.
Recruiting clinical trials with at least one study location in Washington D.C.. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington D.C.
Breast Cancer (6)Head and Neck Squamous Cell Carcinoma (3)Esophageal Cancer (3)Prostate Cancer (3)Prostate Adenocarcinoma (3)Chronic Inflammatory Demyelinating Polyneuropathy (2)Bladder Cancer (2)Multiple Sclerosis (2)Stage IV Lung Cancer AJCC v8 (2)High Grade Glioma (2)Diffuse Intrinsic Pontine Glioma (2)Asthma (2)
Frequently Asked Questions — Clinical Trials in Washington D.C.
How many clinical trials are currently recruiting in Washington D.C.?
ClinicalMetric currently tracks 145 actively recruiting clinical trials with at least one location in Washington D.C.. The total number of registered studies—including active but not currently enrolling trials—is 145. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Washington D.C.?
Washington D.C. hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Head and Neck Squamous Cell Carcinoma, Esophageal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington D.C. serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Washington D.C.?
To join a clinical trial in Washington D.C., browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington D.C. maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Washington D.C.
NCT06041594 N/A
Recruiting
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
Condition
Pulmonary Embolism
Enrollment
107 pts
Location
United States, Turkey (Türkiye)
Sponsor
Innova Vascular, Inc.
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT06070012 Phase 2
Recruiting
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanom...
Condition
Uveal Melanoma
Enrollment
44 pts
Location
United States
Sponsor
Diwakar Davar
NCT05389293 Phase 2
Recruiting
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Ly...
Condition
Follicular Lymphoma
Enrollment
152 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06536881 N/A
Recruiting
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Condition
Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca
NCT06948825 Phase 2
Recruiting
Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With...
Condition
Weight Loss
Enrollment
60 pts
Location
United States
Sponsor
George Washington University
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
NCT04865887 Phase 2
Recruiting
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
Condition
Cervical Cancer
Enrollment
35 pts
Location
United States
Sponsor
Georgetown University
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT05795439 N/A
Recruiting
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
Condition
Type2diabetes
Enrollment
700 pts
Location
United States
Sponsor
Physicians Committee for Respo
NCT06758401 Phase 3
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvot...
Condition
Non-Small Cell Lung Cancer
Enrollment
714 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT05503264 Phase 3
Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodyn...
Condition
NMDAR Autoimmune Encephalitis
Enrollment
152 pts
Location
United States, Argentina, Austria
Sponsor
Hoffmann-La Roche
NCT05230511 Phase 2
Recruiting
Intravesical LGG VS Saline Bladder Wash RCT
Condition
Spinal Cord Injuries
Enrollment
120 pts
Location
United States
Sponsor
Medstar Health Research Instit
NCT06610825 Phase 2
Recruiting
Castrate Resistant Prostate Cancer Enhertu Therapy
Condition
Prostate Cancer Metastatic
Enrollment
60 pts
Location
United States
Sponsor
Washington D.C. Veterans Affai
NCT06578247 Phase 3
Recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-I...
Condition
Leukemia
Enrollment
700 pts
Location
United States, Australia, Austria
Sponsor
Daiichi Sankyo
NCT05135091 Phase 3
Recruiting
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Tempo...
Condition
Mesial Temporal Lobe Epilepsy
Enrollment
88 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT05948943 Phase 2, Phase 3
Recruiting
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associate...
Condition
Lymphatic Malformations
Enrollment
232 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT05155501 N/A
Recruiting
Clinical Trial of Approaches to Prostate Cancer Surgery
Condition
Prostate Cancer
Enrollment
600 pts
Location
United States
Sponsor
Weill Medical College of Corne
NCT05658731 N/A
Recruiting
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pedia...
Condition
Brain Tumor
Enrollment
338 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca
NCT05671419 N/A
Recruiting
Mindful Self-Compassion for Anxiety Disorders and Depression
Condition
Anxiety Disorders
Enrollment
40 pts
Location
United States
Sponsor
Georgetown University
NCT06760637 Phase 3
Recruiting
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Bre...
Condition
Breast Cancer
Enrollment
1,020 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT05434234 Phase 1, Phase 2
Recruiting
A Study of YL201 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
312 pts
Location
United States, Canada, China
Sponsor
MediLink Therapeutics (Suzhou)
NCT05457283 Phase 3
Recruiting
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-t...
Condition
Chronic Kidney Disease
Enrollment
100 pts
Location
United States, Argentina, Australia
Sponsor
Bayer
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology